The pharmaceutical cocrystal landscape of ethenzamide has been addressed during the
past years with the aim of improving its physicochemical properties, mainly solubility and …

Pharmaceutical cocrystals/cocrystal hydrate of ethenzamide (ETZ) with various hydroxy-acid
coformers namely 2, 4-dihydroxybenzoic acid (24DHBA), 3, 5-dihydroxybenzoic acid …

Pharmaceutical cocrystals involving an analgesic drug, ethenzamide (EA) and coformers,
such as salicylic acid (SA), 2-chloro-4-nitrobenzoic acid (CNBA), vanillic acid (VA), 4 …

Ethenzamide (ET) was screened in cocrystallization experiments with pharmaceutically
acceptable coformer molecules to discover materials of improved physicochemical …

Pharmaceutical cocrystals can offer another advanced strategy for drug preparation and
development and can facilitate improvements to the physicochemical properties of active …

Pharmaceutical cocrystals of an analgesic drug ethenzamide (ETZ) with various coformers,
namely, gallic acid (GA), 2-nitrobenzoic acid (2NB), 3-nitrobenzoic acid (3NB), 2, 4 …

The aim of this study was to evaluate the stability and solubility of the polymorphic forms of
the ethenzamide (ET)–gentisic acid (GA) cocrystals during standard technological …

The emergence of cocrystals as alternative solid forms for development of novel drug
products signifies the relevance of polymorphism studies in cocrystals. We report two novel …

Cocrystal formation may affect manufacturability (flow, compaction and processability) as
well as solubility/dissolution, hygroscopicity and stability properties of drugs. Therefore …

Pharmaceutical multicomponent solids have proved to efficiently modulate the
physicochemical properties of active pharmaceutical ingredients. In this context …